EUVIMEDOpdag EUVIMED
Crossref

Bicarbonate transporter SLC4A7 promotes EMT and metastasis of HNSCC by activating the PI3K/AKT/mTOR signaling pathway

Junli Hu, Guo Li, Zhifeng Liu, Huiling Ma, Wenhui Yuan, Zhaoyi Lu, Diekuo Zhang, Hang Ling, Fengyu Zhang, Yong Liu, Chao Liu iD, Yuanzheng Qiu

Molecular Carcinogenesis · 2023-05 · 62 (5) · 628-640

DOI: 10.1002/mc.23511 ↗

At a glance

Journal article in Molecular Carcinogenesis, 2023-05. Written by Junli Hu and 11 co-authors. Institution: Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, China. Major MEDLINE topics: Proto-Oncogene Proteins c-akt, Head and Neck Neoplasms. Cited 20 times so far (Crossref); 39 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide. Currently, therapeutic modalities such as surgery, chemotherapy, radiotherapy, and immunotherapy are being used to treat HNSCC. However, the treatment outcomes of most patients are dismal because they are already in middle or advanced stage by the time of diagnosis and poorly responsive to treatments. It is therefore of great interest to clarify mechanisms that contribute to the metastasis of cells to identify possible targets for therapy. In this study, we identified the Na + ‐coupled bicarbonate transporter, SLC4A7, play essential roles in the metastasis of HNSCC. Our results showed that the relative expression of SLC4A7 messenger RNA was highly expressed in HNSCCs samples from TCGA, and compared with precancerous cells of human oral mucosa (DOK), SLC4A7 was highly expressed in HNSCC cell lines. In vitro and in vivo experiments showed that dysregulation of SLC4A7 had minor influence on the proliferation of HNSCC but impacted HNSCC's migration and invasion. Meanwhile, SLC4A7 could promote epithelial‐mesenchymal transition (EMT) in HNSCC. RNA‐seq, KEGG pathway enrichment analysis and Western blot further revealed that downregulation of SLC4A7 in HNSCC cells inhibited the PI3K/AKT pathway. These findings were further validated via rescue experiments using a small molecule inhibitor of PI3K/mTOR (GDC‐0980). Our findings suggest that SLC4A7 promotes EMT and metastasis of HNSCC through the PI3K/AKT/mTOR signaling pathway, which may be a valuable predictive biomarker and potential therapeutic target in HNSCC.

Subjects

MeSH terms (MEDLINE)

Proto-Oncogene Proteins c-aktHead and Neck NeoplasmsHumansSquamous Cell Carcinoma of Head and NeckPhosphatidylinositol 3-KinasesBicarbonatesEpithelial-Mesenchymal TransitionSignal TransductionTOR Serine-Threonine KinasesCell Line, TumorCell ProliferationCell MovementSodium-Bicarbonate Symporters

Author keywords

PI3K/AKT/mTOR signaling pathwaySLC4A7epithelial-mesenchymal transitionhead and neck squamous cell carcinomametastasis

Substances

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesBicarbonatesTOR Serine-Threonine KinasesMTOR protein, humanSLC4A7 protein, humanSodium-Bicarbonate Symporters

Authors and institutions

  • Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, China.
  • Otolaryngology Major Disease Research Key Laboratory of Hunan Province, Changsha, China.
  • Clinical Research Center for Pharyngolaryngeal Diseases and Voice Disorders in Hunan Province, Changsha, China.
  • Department of Otolaryngology Head and Neck Surgery, Yantian District People's Hospital, Shenzhen, Guangdong, China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.

ORCID profiles: Chao Liu

Cite

APA

Hu, J., Li, G., Liu, Z., Ma, H., Yuan, W., Lu, Z., Zhang, D., Ling, H., Zhang, F., Liu, Y., Liu, C., & Qiu, Y. (2023). Bicarbonate transporter SLC4A7 promotes EMT and metastasis of HNSCC by activating the PI3K/AKT/mTOR signaling pathway. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23511

Vancouver

Hu J, Li G, Liu Z, Ma H, Yuan W, Lu Z, et al. Bicarbonate transporter SLC4A7 promotes EMT and metastasis of HNSCC by activating the PI3K/AKT/mTOR signaling pathway. Molecular Carcinogenesis. 2023. doi:10.1002/mc.23511

BibTeX
@article{Hu2023,
  author = {Hu, Junli and Li, Guo and Liu, Zhifeng and Ma, Huiling and Yuan, Wenhui and Lu, Zhaoyi and Zhang, Diekuo and Ling, Hang and Zhang, Fengyu and Liu, Yong and Liu, Chao and Qiu, Yuanzheng},
  title = {Bicarbonate transporter SLC4A7 promotes EMT and metastasis of HNSCC by activating the PI3K/AKT/mTOR signaling pathway},
  journal = {Molecular Carcinogenesis},
  year = {2023},
  doi = {10.1002/mc.23511}
}
Start for free →